KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Cash from Investing Activities (2016 - 2025)

Fulgent Genetics' Cash from Investing Activities history spans 10 years, with the latest figure at $11.2 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 140.63% year-over-year to $11.2 million; the TTM value through Dec 2025 reached $111.4 million, up 290.86%, while the annual FY2025 figure was $111.4 million, 290.86% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was $11.2 million at Fulgent Genetics, down from $19.1 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $53.4 million in Q2 2025 and bottomed at -$216.5 million in Q1 2021.
  • The 5-year median for Cash from Investing Activities is -$204000.0 (2022), against an average of -$35.8 million.
  • The largest annual shift saw Cash from Investing Activities tumbled 6345.11% in 2021 before it skyrocketed 766.42% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$140.3 million in 2021, then soared by 33.98% to -$92.6 million in 2022, then skyrocketed by 126.21% to $24.3 million in 2023, then plummeted by 213.12% to -$27.5 million in 2024, then soared by 140.63% to $11.2 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Cash from Investing Activities are $11.2 million (Q4 2025), $19.1 million (Q3 2025), and $53.4 million (Q2 2025).